Concepedia

Author

Dimitris Mavroudis

University Hospital of Heraklion

Also Known As

Dimitris Mavroudis

147

Publications

7.1K

Citations

46

H-Index

77

Concepts

All Affiliations

University Hospital of HeraklionUniversity of CreteNational and Kapodistrian University of Athens
DM

About

Dimitris Mavroudis is an author at University Hospital of Heraklion specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

39

2.5K

2

Cell Biology

11

12

788

3

Public Health

4

4

179

4

Health Sciences

3

3

637

5

Biology

1

1

11

Dimitris Mavroudis

×

81

Publications

6.6K

Citations

45

H-Index

YearCitations

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen,

The Lancet Oncology

2017

578

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Galatea Kallergi, Maria A. Papadaki, Eleni Politaki,

Breast Cancer Research

2011

372

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Panayiotis A. Theodoropoulos, Hara Polioudaki, Sofia Agelaki,

Cancer Letters

2009

285

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients

N. Xenidis, Maria Perraki, Maria Kafousi,

Journal of Clinical Oncology

2006

265

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer

Michail Ignatiadis, N. Xenidis, Maria Perraki,

Journal of Clinical Oncology

2007

240

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Nikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki,

Journal of Clinical Oncology

2009

240

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia,

Clinical Cancer Research

2008

231

Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

Maria A. Papadaki, Giannis Stoupis, Panayiotis A. Theodoropoulos,

Molecular Cancer Therapeutics

2018

201

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

Aliki Stathopoulou, Anna Gizi, Maria Perraki,

PubMed

2003

164

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

Galatea Kallergi, Sofia Agelaki, A. Kalykaki,

Breast Cancer Research

2008

150

Page 1